Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- Fresenius Medical Care named Shervin Korangy as CEO Posted 10-22-2026
- Aligning Clinical Excellence with Health System Goals Through PD in Value-Based Models Posted 10-22-2026
- Update on National Institutes of Health websites Posted 10-22-2026
- What to Know About the American Society of Nephrology Kidney Week Posted 10-22-2026

